Skip to main content
Premium Trial:

Request an Annual Quote

NCI Renews Site License for Ariadne Pathway Studio


The National Cancer Institute has renewed its license for Ariadne's Pathway Studio Enterprise system, which includes the ResNet Mammalian database and Ariadne MedScan text processing technology.

Ilya Mazo, Ariadne’s president, said in a statement that the firm “welcome[s]” the opportunity to provide its “bioinformatics expertise” to help NCI researchers with data capture and curation and to support collaborations between research institutes.

Pathway Studio lets researchers create new cancer disease pathways and develop rationales for diseases based on molecular facts from public data and research findings using MedScan.

The tool uses a workflow approach that allows researchers to mine, integrate, analyze, and visualize results individually or as an integrated workflow. Each step can be saved and updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.

Last month, Pathway studio was tapped to support cancer research endeavors at Georgetown University (BI 02/11/2011).

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.